BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1469633)

  • 1. Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides: a comparative study of the 5-hydroxytryptamine1A and adenosine A1 receptor systems in rat hippocampal membranes.
    Mahle CD; Wiener HL; Yocca FD; Maayani S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1275-84. PubMed ID: 1469633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
    Ramkumar V; Stiles GL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
    Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A
    J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
    Quist E; Satumtira N; Vasan R
    Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK; Meeker RB; Martin MW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
    Leid M; Schimerlik MI; Murray TF
    Mol Pharmacol; 1989 Apr; 35(4):450-7. PubMed ID: 2495433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding.
    Lorenzen A; Fuss M; Vogt H; Schwabe U
    Mol Pharmacol; 1993 Jul; 44(1):115-23. PubMed ID: 8341267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in the effect of guanine nucleotides on agonist and antagonist binding to adenosine A1-receptors in rat brain, as revealed by autoradiography.
    Fastbom J; Fredholm BB
    Neuroscience; 1990; 34(3):759-69. PubMed ID: 2352651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.
    Stiles GL
    J Neurochem; 1988 Nov; 51(5):1592-8. PubMed ID: 3139838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
    Leid M; Schimerlik MI; Murray TF
    Mol Pharmacol; 1988 Sep; 34(3):334-9. PubMed ID: 3047553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition.
    Blair TA; Parenti M; Murray TF
    Mol Pharmacol; 1989 May; 35(5):661-70. PubMed ID: 2498636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.